company background image
ORIONINFU logo

Orion Infusion DSE:ORIONINFU Stock Report

Last Price

৳484.90

Market Cap

৳9.9b

7D

7.0%

1Y

47.2%

Updated

21 Jun, 2024

Data

Company Financials

Orion Infusion Limited

DSE:ORIONINFU Stock Report

Market Cap: ৳9.9b

ORIONINFU Stock Overview

Engages in the manufacture and sale of large volume parenteral and other lifesaving injectable products in Bangladesh.

ORIONINFU fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health3/6
Dividends0/6

Orion Infusion Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Orion Infusion
Historical stock prices
Current Share Price৳484.90
52 Week High৳726.90
52 Week Low৳284.20
Beta-1.79
11 Month Change-17.08%
3 Month Change-13.84%
1 Year Change47.21%
33 Year Change604.80%
5 Year Change764.35%
Change since IPO3,940.85%

Recent News & Updates

Recent updates

Shareholder Returns

ORIONINFUBD PharmaceuticalsBD Market
7D7.0%4.2%3.0%
1Y47.2%-20.5%-24.2%

Return vs Industry: ORIONINFU exceeded the BD Pharmaceuticals industry which returned -20.5% over the past year.

Return vs Market: ORIONINFU exceeded the BD Market which returned -24.2% over the past year.

Price Volatility

Is ORIONINFU's price volatile compared to industry and market?
ORIONINFU volatility
ORIONINFU Average Weekly Movement8.2%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement5.4%
10% most volatile stocks in BD Market7.6%
10% least volatile stocks in BD Market3.4%

Stable Share Price: ORIONINFU's share price has been volatile over the past 3 months.

Volatility Over Time: ORIONINFU's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of BD stocks.

About the Company

FoundedEmployeesCEOWebsite
1983764Salman Karimwww.orioninfusion.com

Orion Infusion Limited engages in the manufacture and sale of large volume parenteral and other lifesaving injectable products in Bangladesh. It offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; Metronidazole I.V; pure steam generated fluids; and amino acids solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd.

Orion Infusion Limited Fundamentals Summary

How do Orion Infusion's earnings and revenue compare to its market cap?
ORIONINFU fundamental statistics
Market cap৳9.87b
Earnings (TTM)৳42.70m
Revenue (TTM)৳850.39m

231.2x

P/E Ratio

11.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ORIONINFU income statement (TTM)
Revenue৳850.39m
Cost of Revenue৳508.52m
Gross Profit৳341.87m
Other Expenses৳299.17m
Earnings৳42.70m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.10
Gross Margin40.20%
Net Profit Margin5.02%
Debt/Equity Ratio93.9%

How did ORIONINFU perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

48%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.